Revvity Adjusts Revenue Forecast But Lifts Profit Expectations

Despite facing challenges from a slowdown in biotech spending and a strong US dollar, Revvity has adjusted its financial outlook, lowering revenue forecasts but ...

Revvity cuts 2024 revenue forecast amid biotech spending slowdown

Revvity cut its 2024 revenue forecast as reduced biotech spending and a strong dollar weigh on demand for its tools and services used in ...

Revvity Announces Financial Results for the Third Quarter of 2024

Revenue of $684 million; 2% reported growth; 2% organic growth GAAP EPS of $0.77; Adjusted EPS from continuing operations of $1.28 Raises ...

Revvity Announces Financial Results for the Third Quarter of 2024

Revenue of $684 million; 2% reported growth; 2% organic growth · GAAP EPS of $0.77; Adjusted EPS from continuing operations of $1.28 · Raises full ...

Revvity beats Q3 expectations, raises full-year EPS outlook

For the third quarter ended September 29, 2024, Revvity posted adjusted earnings per share of $1.28, beating the analyst consensus of $1.13 by ...

Life Science Firm Revvity Lifts Annual Profit Forecast On Strong Q2 ...

Guidance: Revvity updates its fiscal year 2024 sales guidance to $2.77 billion—$2.79 billion, compared to prior guidance of $2.76 billion—$2.82 ...

Revvity Announces Financial Results for the Third Quarter of 2024

Adjusted operating income was $193 million, as compared to $185 million for the same period a year ago. Adjusted operating profit margin was ...

Revvity raises 2024 profit forecast on medical equipment demand

Revvity forecast annual adjusted profit between $4.70 and $4.80 per share, up from its prior view of $4.55 to $4.75. Analysts were expecting a profit of $4.63 ...

Revvity Announces Financial Results for the Third Quarter of 2024

... revenue, 6% Diagnostics growth, and raises 2024 EPS outlook. Learn ... adjusted operating income as a percentage of adjusted revenue.

Danaher - Finimize

Discover recent investing articles from Finimize about. #Danaher. News. Revvity Adjusts Revenue Forecast But Lifts Profit Expectations ...

Financials - Quarterly Results - Revvity, Inc. - Investor Relations

Adjusted operating profit margin was 34.2% as a percentage of adjusted revenue, as compared to 37.1% in the same period a year ago. Diagnostics. Third quarter ...

BUZZ-Revvity climbs after raising 2024 profit forecast - LongPort

Favorable margins and a lower tax rate contributed to this profit beat. However, Revvity expects annual revenue to be between $0.75 billion and ...

Diagnostic Products Demand Boosts Profit and Sales at Revvity

Revvity (RVTY) shares advanced Monday after the medical equipment maker formerly known as PerkinElmer posted better-than-expected results and boosted its ...

Revvity, Inc. Q1 Profit Down, But Beats Street; Updates Annual Outlook

The company still expects adjusted income per share of $4.55 to $4.75, in line with analysts' estimate of $4.65 per share. To reflect recent ...

Revvity, Inc. NYSE:RVTY

Revvity Q2 Revenues Down on COVID Testing Declines; Organic ...

The firm reported 8 percent organic growth in diagnostics, excluding COVID-19, but it also saw lower spending on instruments, contracts, ...

PerkinElmer Q1 Profit Rises; Lifts FY10 EPS View - Quick Facts

Analysts polled by Thomson Reuters expected the company to report earnings of $0.29 per share on revenues of $446.78 million for the quarter. Analysts' ...

PayPal's revenue forecast fails to impress as profit push puts growth ...

The company expects fourth-quarter revenue to grow by a "low single-digit" percentage compared with the 5.4% increase expected by analysts ...

Revvity Earnings: Key Markets Still Uncertain, But Some Relief ...

We still estimate about 5% growth compounded annually through 2027 for both revenue and adjusted EPS, driven in part by strong recurring revenue ...

Revenue Outlook - Oregon.gov

In addition to the surprising corporate income tax collections, forecasts for estate and liquor taxes have seen large revisions relative to the ...